PHASE II, DOUBLE-BLIND, DOSE-SEARCHED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SCH 420814 AS ADJUVANT THERAPY TO L-DOPA / DESPABOXYLASE DOPA INHIBITOR IN SUBJECTS WITH PARKINSON´S DISEASE.

Category Primary study
Registry of TrialsClinical Trials Peruvian Registry
Year 2003
This article has no abstract
Epistemonikos ID: f098eeb9cfc5aa70c449f28b91db561cf5bc6378
First added on: Apr 16, 2025